Corient Capital Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Corient Capital Partners’s Portfolio ALNY Stock Details ALNY Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$309K	Hold
2022 Q2	$309K	Sell
2022 Q1	$372K	Sell
2021 Q4	$392K	Buy
2021 Q3	$429K	Buy
2021 Q2	$344K	Buy
2021 Q1	$258K	Buy
2020 Q4	$209K	Buy
2020 Q3	–	Sell
2020 Q2	$216K	Buy